About this trial
By 2030, depression will be the leading global disease burden. Postnatal depression due to childbirth/parenting leads to long-term negative consequences for mothers, their children and their families. The British African/Caribbean communities are worse hit by the unprecedented impact of post-Covid-19-syndromes, leading to an exponential increase in postnatal depression. Yet, the uptake of mental healthcare by British mothers of African and Caribbean origin is low due to limited access to culturally appropriate care. Theories of attachment and cognitivism were innovatively integrated to examine Learning-Through-Play plus (LTP+) intervention for postnatal depression using a pilot randomised controlled trial. The proposed LTP+ is co-developed and ecologically friendly because it is manualised and can be delivered by non-mental health specialists such as trained community health workers who are more culturally knowledgeable. Findings will be disseminated through academic publications/presentations, policy briefs, original animated videos and podcast series laying the foundations for a psychosocial approach to tackling postnatal depression
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
experiencing emotional distress due to childbirth or parenting and scored 5 or above on the patient health questionnaire (PHQ-9)
who have children age 0-3 years
residents of designated communities and available for follow-up
are 18 years and above
Disqualifiers
with a medical condition that would prevent their participation such as active suicidal ideation, tuberculosis, or heart failure
temporary residents are unlikely to be available for follow up
who are less than 18 years
unable to provide consent.
Trial design
Parallel
Treatments tested in this trial
Learning Through Play plus (LTP+)
BehavioralGroup-1: Experimental (n=40 participants) will receive the LTP+ which consist of a total of 12-group integrated treatment sessions lasting approximately 60-90 minutes per session every fortnight with 10 mother/child pair per sub-group.
Psychoeducation
BehavioralGroup-2: Controlled (n=40 participants) will receive 'psychoeducation' which consist of a total of 12-group sessions lasting approximately 60-90 minutes per session every fortnight with 10 mother-child pair per sub-group.
Treatment groups
Trial outcomes
Primary outcomes
Change in postnatal depression is being assessed
Primary outcome measure would be assessed using the Patient Health Questionnaire (PHQ-9)
Change in postnatal anxiety is being assessed
Primary outcome measure would be assessed using the Generalised Anxiety Disorder (GAD7) scale
Change in social support is being assessed
Primary outcome measures would be assessed using the Oslo Social Support Scale
Change in health-related quality of life is being assessed
Outcome measure would be assessed using the Health-related Quality of Life scale (EuroQoL-5 Dimensions)
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: